Show simple item record

dc.contributor.authorSheppard, EC
dc.contributor.authorMorrish, RB
dc.contributor.authorDillon, MJ
dc.contributor.authorLeyland, R
dc.contributor.authorChahwan, R
dc.date.accessioned2018-03-15T16:19:44Z
dc.date.issued2018-02-26
dc.description.abstractEpigenetic modifications, such as histone modifications, DNA methylation status, and non-coding RNAs (ncRNA), all contribute to antibody maturation during somatic hypermutation (SHM) and class-switch recombination (CSR). Histone modifications alter the chromatin landscape and, together with DNA primary and tertiary structures, they help recruit Activation-Induced Cytidine Deaminase (AID) to the immunoglobulin (Ig) locus. AID is a potent DNA mutator, which catalyzes cytosine-to-uracil deamination on single-stranded DNA to create U:G mismatches. It has been shown that alternate chromatin modifications, in concert with ncRNAs and potentially DNA methylation, regulate AID recruitment and stabilize DNA repair factors. We, hereby, assess the combination of these distinct modifications and discuss how they contribute to initiating differential DNA repair pathways at the Ig locus, which ultimately leads to enhanced antibody-antigen binding affinity (SHM) or antibody isotype switching (CSR). We will also highlight how misregulation of epigenomic regulation during DNA repair can compromise antibody development and lead to a number of immunological syndromes and cancer.en_GB
dc.description.sponsorshipThe authors wish to thank Matthew Scharff, Shanzhi Wang, Sergio Roa, and Emma Knight for their insight, and funding for RC from the Biotechnology and Biological Research Council [BB/N017773/1], Royal Society [IE150290], and Academy of Medical Sciences Springboard Award. ECS and RBM are funded by Ph.D. studentships from the Biotechnology and Biological Research Council-funded South West Doctoral Training Partnership [BB/J014400/1] and the Engineering and Physical Sciences Research Council-funded Doctoral Training Partnership [EP/M506527/1], respectively.en_GB
dc.identifier.citationVol. 9, article 355en_GB
dc.identifier.doi10.3389/fimmu.2018.00355
dc.identifier.urihttp://hdl.handle.net/10871/32128
dc.language.isoenen_GB
dc.publisherFrontiers Mediaen_GB
dc.rightsCopyright © 2018 Sheppard, Morrish, Dillon, Leyland and Chahwan. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.en_GB
dc.subjectepigenetic modificationsen_GB
dc.subjectepigenomicsen_GB
dc.subjectepigeneticsen_GB
dc.subjectantibody diversityen_GB
dc.subjectcytosine deaminationen_GB
dc.subjectsomatic hypermutationen_GB
dc.subjectclass-switch recombinationen_GB
dc.subjectB cell maturationen_GB
dc.titleEpigenomic modifications mediating antibody maturationen_GB
dc.typeArticleen_GB
dc.date.available2018-03-15T16:19:44Z
dc.identifier.issn1664-3224
dc.descriptionThis is the final version of the article. Available from the publisher via the DOI in this record.en_GB
dc.identifier.journalFrontiers in Immunologyen_GB


Files in this item

This item appears in the following Collection(s)

Show simple item record